Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Clin Microbiol ; 53(5): 1715-8, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25694525

RESUMEN

One year after a virulent Newcastle disease virus (vNDV) outbreak in Pakistan, the causative strain was present in vaccinated chickens of multiple farms despite the existence of high-average NDV-specific antibody titers (>4.75 log2). The data suggest a possible role of vaccinated birds as reservoirs of vNDV.


Asunto(s)
Portador Sano/veterinaria , Pollos/virología , Virus de la Enfermedad de Newcastle/aislamiento & purificación , Agricultura , Animales , Anticuerpos Antivirales/sangre , Portador Sano/virología , Datos de Secuencia Molecular , Virus de la Enfermedad de Newcastle/inmunología , Pakistán , ARN Viral/genética , Análisis de Secuencia de ADN
2.
Clin J Gastroenterol ; 16(1): 39-42, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36251246

RESUMEN

Post-transplant lymphoproliferative disorder (PTLD) is a rare complication of solid organ transplantation as the result of immunosuppressant medications. Epstein-Barr virus (EBV) has been implicated in most of these cases, specifically with B-cell predominant lymphoma. This case report describes a 24-year-old female who presented with recurrent GI bleed within 6 months post-orthostatic heart transplant. Endoscopic evaluations including video capsule study, push enteroscopy, and colonoscopy revealed multiple ulcerated lesions in duodenum, jejunum, and colon secondary to Epstein-Barr Virus-associated monomorphic PTLD. Despite continuation of rituximab after discharge, she returned to the hospital for recurrent GI bleed requiring additional endoscopic intervention. PTLD is a devastating disease of the post-transplant population. Due to a high risk of recurrent GI bleeding, patients with PTLD may benefit from careful monitoring by gastroenterology as an outpatient with a low threshold for repeat endoscopic evaluation despite being on immunotherapy or chemotherapy.


Asunto(s)
Infecciones por Virus de Epstein-Barr , Trastornos Linfoproliferativos , Femenino , Humanos , Adulto Joven , Adulto , Infecciones por Virus de Epstein-Barr/complicaciones , Herpesvirus Humano 4 , Úlcera/etiología , Duodeno/patología , Trastornos Linfoproliferativos/etiología , Trastornos Linfoproliferativos/patología
3.
Case Rep Oncol ; 15(3): 874-880, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36825101

RESUMEN

A diagnosis of acute myeloid leukemia involving the central nervous system (CNS) can be confirmed through cerebrospinal fluid (CSF) and serum flow cytometry. These two detection methods should demonstrate the same immunophenotype due to hematogenous dissemination. Here, we reported a 65-year-old male diagnosed with CNS leukemia with differing immunophenotypes between CSF and peripheral blood. This immunophenotypic shift may suggest leukemic migration within the blood-brain barrier. In addition, the case highlights the concept of leukemic heterogeneity and the importance of considering cancer heterogeneity when analyzing a tumor's genetic profile and selecting therapy for patients.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA